Use of a continuous glucose sensor in an extracorporeal life support circuit

Journal of Diabetes Science and Technology

Volumn 5, Issue 1, 2011, Pages 93-98

  Steil, Garry M ^a   Alexander, Jamin ^a   Papas, Alexandra ^a   Langer, Monica ^a   Modi, Biren P ^a   Piper, Hannah ^a   Jaksic, Tom ^a   Gottlieb, Rebecca ^b   Agus, Michael S D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MEDTRONIC INC   (United States)

Author keywords

Cardiopulmonary bypass; Continuous monitor; Extracorporeal; Extracorporeal life support; Glucose

Indexed keywords

GLUCOSE;

ANALYZER; ARTICLE; CALIBRATION; CHILD; CLINICAL ARTICLE; COMPUTER PROGRAM; EXTRACORPOREAL LIFE SUPPORT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HUMAN; INFANT; INTENSIVE CARE; MALE; NEWBORN; PEDIATRIC ADVANCED LIFE SUPPORT; PRESCHOOL CHILD; RETROSPECTIVE STUDY; BLOOD; BLOOD GLUCOSE MONITORING; CONGENITAL DIAPHRAGM HERNIA; CONGENITAL HEART MALFORMATION; DIAPHRAGM HERNIA; EVALUATION; EXTRACORPOREAL CIRCULATION; GENETIC PROCEDURES; INSTRUMENTATION; METHODOLOGY; MONITORING; NEWBORN DISEASE; RESPIRATORY FAILURE; STANDARD; UTILIZATION REVIEW;

BIOSENSING TECHNIQUES; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CALIBRATION; CHILD, PRESCHOOL; EXTRACORPOREAL CIRCULATION; FEMALE; HEART DEFECTS, CONGENITAL; HERNIA, DIAPHRAGMATIC; HUMANS; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; MONITORING, PHYSIOLOGIC; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 79958006393     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500113     Document Type: Article

References (28)

1. Conrad SA, Rycus PT, Dalton H. Extracorporeal Life Support Registry Report 2004. ASAIO J. 2005;51(1):4-10.
2. Kyle UG, Jolliet P, Genton L, Meier CA, Mensi N, Graf JD, Chevrolet JC, Pichard C. Clinical evaluation of hormonal stress state in medical ICU patients: a prospective blinded observational study. Intensive Care Med. 2005;31(12):1669-75.
3. Glass P, Wagner AE, Papero PH, Rajasingham SR, Civitello LA, Kjaer MS, Coffman CE, Getson PR, Short BL. Neurodevelopmental status at age five years of neonates treated with extracorporeal membrane oxygenation. J Pediatr. 1995;127(3):447-57.
4. Short BL. The effect of extracorporeal life support on the brain: a focus on ECMO. Semin Perinatol. 2005;29(1):45-50.
5. Renard E, Costalat G, Chevassus H, Bringer J. Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system. Diabetes Metab. 2006;32(5 Pt 2):497-502.
6. Javid PJ, Halwick DR, Betit P, Thompson JE, Long K, Zhang Y, Jaksic T, Agus MS. The first use of live continuous glucose monitoring in patients on extracorporeal life support. Diabetes Technol Ther. 2005;7(3):431-9.
7. Steil GM, Rebrin K, Mastrototaro J, Bernaba B, Saad MF. Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. Diabetes Technol Ther. 2003;5(1):27-31.
8. Steil GM, Rebrin K, Hariri F, Jinagonda S, Tadros S, Darwin C, Saad MF. Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia. Diabetologia. 2005;48(9):1833-40.
9. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes. 2006;55(12):3344-50.
10. Panteleon AE, Rebrin K, Steil GM. The role of the independent variable to glucose sensor calibration. Diabetes Technol Ther. 2003;5(3):401-10.
11. Keenan DB, Cartaya R, Mastrototaro JJ. Accuracy of a new real-time continuous glucose monitoring algorithm. J Diabetes Sci Technol. 2010;4(1):111-8.
12. Rebrin K, Sheppard NF Jr, Steil GM. Use of subcutaneous interstitial fluid glucose to estimate blood glucose: revisiting delay and sensor offset. J Diabetes Sci Technol. 2010;4(5):1087-98.
13. Henninger N, Woderer S, Kloetzer HM, Staib A, Gillen R, Li L, Yu X, Gretz N, Kraenzlin B, Pill J. Tissue response to subcutaneous implantation of glucose-oxidase-based glucose sensors in rats. Biosens Bioelectron. 2007;23(1):26-34.
14. Chen T, Schmidtke DW, Heller A. Defining the period of recovery of the glucose concentration after its local perturbation by the implantation of a miniature sensor. Clin Chem Lab Med. 2002;40(8):786-9.
15. Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, Tamborlane WV. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care. 2002;25(5):889-93.
16. Voskanyan G, Barry Keenan D, Mastrototaro JJ, Steil GM. Putative delays in interstitial fluid (ISF) glucose kinetics can be attributed to the glucose sensing systems used to measure them rather than the delay in ISF glucose itself. J Diabetes Sci Technol. 2007;1(5):639-44.
17. Stout PJ, Racchini JR, Hilgers ME. A novel approach to mitigating the physiological lag between blood and interstitial fluid glucose measurements. Diabetes Technol Ther. 2004;6(5):635-44.
18. Youssef JE, Castle JR, Engle JM, Massoud RG, Ward WK. Continuous glucose monitoring in subjects with type 1 diabetes: improvement in accuracy by correcting for background current. Diabetes Technol Ther. 2010;12(11):921-8.
19. Agus MS, Javid PJ, Ryan DP, Jaksic T. Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygenation. J Pediatr Surg. 2004;39(6):839-44.
20. Agus MS, Javid PJ, Piper HG, Wypij D, Duggan CP, Ryan DP, Jaksic T. The effect of insulin infusion upon protein metabolism in neonates on extracorporeal life support. Ann Surg. 2006;244(4):536-44.
21. Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V, Borger MA. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2005;130(4):1144.
22. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10 Suppl 2:21-33.
23. Najmaii S, Redford D, Larson DF. Hyperglycemia as an effect of cardiopulmonary bypass: intra-operative glucose management. J Extra Corpor Technol. 2006;38(2):168-73.
24. Preissig CM, Rigby MR. Pediatric critical illness hyperglycemia: risk factors associated with development and severity of hyperglycemia in critically ill children. J Pediatr. 2009;155(5):734-9.
25. Carvalho G, Moore A, Qizilbash B, Lachapelle K, Schricker T. Maintenance of normoglycemia during cardiac surgery. Anesth Analg. 2004;99(2):319-24.
26. Chaney MA, Nikolov MP, Blakeman BP, Bakhos M. Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. Anesth Analg. 1999;89(5):1091-5.
27. Smith CE, Styn NR, Kalhan S, Pinchak AC, Gill IS, Kramer RP, Sidhu T. Intraoperative glucose control in diabetic and nondiabetic patients during cardiac surgery. J Cardiothorac Vasc Anesth. 2005;19(2):201-8.
28. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-39.